Literature DB >> 18462160

Ehrlichia ewingii infection delays spontaneous neutrophil apoptosis through stabilization of mitochondria.

Qingming Xiong1, Weichao Bao, Yan Ge, Yasuko Rikihisa.   

Abstract

The uncultivable obligate intracellular bacterium Ehrlichia ewingii, previously known only as a canine pathogen, is the most recently recognized agent of human ehrlichiosis. E. ewingii is the only Ehrlichia species known to infect neutrophils. In the blood or in ex vivo culture, neutrophils generally have a short life span. In the present study, we investigated the effect of E. ewingii infection on spontaneous apoptosis of neutrophils. E. ewingii infection significantly delayed dog neutrophil apoptosis during ex vivo culture. The inhibitory effect on neutrophil apoptosis by E. ewingii was reversible on clearance of the organism. By using the fluorescent mitochondrial dyes Mitotracker Red 580 and JC-1, we found that E. ewingii infection stabilized mitochondrial integrity by maintaining mitochondrial membrane potential in neutrophils. These results suggest that E. ewingii delays spontaneous apoptosis of neutrophils via stabilization of host cell mitochondria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462160     DOI: 10.1086/533457

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

Review 1.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

2.  Obligate intracellular bacterium Ehrlichia inhibiting mitochondrial activity.

Authors:  Yan Liu; Zhikai Zhang; Yongquan Jiang; Lihong Zhang; Vsevolod L Popov; Jianzhi Zhang; David H Walker; Xue-jie Yu
Journal:  Microbes Infect       Date:  2010-11-09       Impact factor: 2.700

Review 3.  Cells within cells: Rickettsiales and the obligate intracellular bacterial lifestyle.

Authors:  Jeanne Salje
Journal:  Nat Rev Microbiol       Date:  2021-02-09       Impact factor: 60.633

Review 4.  New insights into molecular Ehrlichia chaffeensis-host interactions.

Authors:  Abdul Wakeel; Bing Zhu; Xue-Jie Yu; Jere W McBride
Journal:  Microbes Infect       Date:  2010-01-29       Impact factor: 2.700

5.  The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation.

Authors:  Xiao Wang; Yujing Bi; Lixiang Xue; Jiongbo Liao; Xi Chen; Yun Lu; Zhengguo Zhang; Jian Wang; Huanrong Liu; Hui Yang; Guangwei Liu
Journal:  Mol Cell Biol       Date:  2014-12-01       Impact factor: 4.272

6.  Ehrlichia chaffeensis TRP120 interacts with a diverse array of eukaryotic proteins involved in transcription, signaling, and cytoskeleton organization.

Authors:  Tian Luo; Jeeba A Kuriakose; Bing Zhu; Abdul Wakeel; Jere W McBride
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

Review 7.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

8.  An Ehrlichia chaffeensis tandem repeat protein interacts with multiple host targets involved in cell signaling, transcriptional regulation, and vesicle trafficking.

Authors:  Abdul Wakeel; Jeeba A Kuriakose; Jere W McBride
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

9.  Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock.

Authors:  Qin Yang; Purnima Ghose; Nahed Ismail
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

10.  Identification of 19 polymorphic major outer membrane protein genes and their immunogenic peptides in Ehrlichia ewingii for use in a serodiagnostic assay.

Authors:  Chunbin Zhang; Qingming Xiong; Takane Kikuchi; Yasuko Rikihisa
Journal:  Clin Vaccine Immunol       Date:  2007-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.